Navigation Links
Will global warming increase plant frost damage?
Date:3/2/2008

Widespread damage to plants from a sudden freeze that occurred across the Eastern United States from 5 April to 9 April 2007 was made worse because it had been preceded by two weeks of unusual warmth, according to an analysis published in the March 2008 issue of BioScience. The authors of the report, Lianhong Gu and his colleagues at the Oak Ridge National Laboratory and collaborators at NASA, the University of Missouri, and the National Oceanic and Atmospheric Administration, found that the freeze killed new leaves, shoots, flowers, and fruit of natural vegetation, caused crown dieback of trees, and led to severe damage to crops in an area encompassing Nebraska, Maryland, South Carolina, and Texas. Subsequent drought limited regrowth.

Rising levels of atmospheric carbon dioxide are believed to reduce the ability of some plants to withstand freezing, and the authors of the BioScience study suggest that global warming could lead to more freeze and thaw fluctuations in future winters. This pattern is potentially dangerous for plants because many species must acclimate to cold over a sustained period. Acclimation enables them to better withstand freezes, but unusual warmth early in the year prevents the process. A cold spring in 1996, in contrast to the 2007 event, caused little enduring damage because it was not preceded by unusual warmth.

The 2007 freeze is likely to have lasting effects on carbon balance in the region. Plants cannot resorb nutrients from dead tissue that would normally be remobilized within the plants during autumnal senescence, so many nutrients became less available for plants in 2008. Wildlife is expected to have suffered harm from lack of food, and changes to plant architecture could have long-term implications.

Gu and his colleagues propose that the 2007 spring freeze should not be viewed as an isolated event, but as a realistic climate-change scenario. Further study of its long-term consequences could help refi
'/>"/>

Contact: Holly Menninger
hmenninger@aibs.org
202-628-1500
American Institute of Biological Sciences
Source:Eurekalert

Page: 1 2

Related biology news :

1. Global Warming and the Habitability of Planet Earth, Sept. 26
2. Green skies: Engineers work may reduce jet travels role in global warming
3. Scientists in first global study of poison gas in the atmosphere
4. North Americas northernmost lake affected by global warming
5. IEEE-USA innovation forum will help prepare US tech leaders to prosper in a global marketplace
6. Majority of Americans want local action on global warming, says poll
7. International team of scientists warns of climate changes impact on global river flow
8. Changing the global dietary environment
9. Global deal fuels QUTs world-changing research
10. NIH hosts event to launch Council of Science Editors global theme issue
11. Agricultural soil erosion is not adding to global warming
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... -- Nxt-ID, Inc. (OTCQB: NXTD), a biometric authentication company ... that its shares of common stock and the warrants ... proposed underwritten public offering of common stock and warrants ... Market, subject to closing of its proposed underwritten public ... trade under the symbol "NXTD" and "NXTDW," respectively. ...
(Date:8/21/2014)... aimed at improving the food intake, health and quality ... is among three projects at the University of Waterloo ... Canadian Institutes of Health Research (CIHR). , Professor ... at Waterloo, and a Schlegel research chair in nutrition ... investigate why many Canadians living in long-term care homes ...
(Date:8/21/2014)... Wednesday, Oct. 18-22, 2014 , WHERE: , ... San Diego, CA 92101 , WHAT: , ... of the latest research in human genetics. Examples ... high-scoring abstracts on rare genetic variants in health ... treatment for sun sensitivity (Saturday, Oct. 18, 5:30-7:30 ...
Breaking Biology News(10 mins):Nxt-ID Approved for NASDAQ Capital Market Listing 2Nxt-ID Approved for NASDAQ Capital Market Listing 3Grants will fund landmark aging research at Waterloo 2American Society of Human Genetics 2014 Annual Meeting 2
... (UW) have reported for the first time that mammals can ... retinas. Located in the back of the eye, the retina,s ... to the brain. The findings on retina self-repair in ... of the Proceedings of the National Academy of Sciences ...
... Institute of Technology has invited a longtime University of ... and presenting seminars on its campus. Fazle Hussain, ... Engineering, was the sole recipient of the Gordon and ... for Caltech,s division of engineering and applied sciences. The ...
... University have answered a fundamental question of how important ... function, a finding that could provide a new target ... diseases. In a study published this month in ... show for the first time that the specific movements ...
Cached Biology News:Mammals can be stimulated to regrow damaged inner retina nerve cells 2Mammals can be stimulated to regrow damaged inner retina nerve cells 3Celebrated UH researcher invited to Caltech as distinguished scholar 2Scientists present 'moving' theory behind bacterial decision-making 2
(Date:8/21/2014)... (PRWEB) August 21, 2014 Pursuit ... selling optimization technology and services for Life Sciences ... “Grading Pharma’s Use of New Commercial Sales Models” ... & Analytics. , The article examines some innovative ... that are being tested in the pharmaceutical market. ...
(Date:8/21/2014)... Louis, MO (PRWEB) August 21, 2014 ... full service biopharmaceutical contract development and manufacturing organization ... by Progenics Pharmaceuticals, Inc., an oncology company focused ... and treating cancer, to manufacture the anti-prostate specific ... PSMA ADC product candidate. Under the agreement ...
(Date:8/21/2014)... On Wednesday of last week RENU 28, ... Signaling molecules, became available for purchase in Australia and New ... that RENU 28 works is, if you think about the ... rate of cellular renewal within your body. If you think ... rate of cellular renewal. What RENU 28 does is it ...
(Date:8/20/2014)... An analysis of patented university inventions licensed to ... path to commercialization. To open these roadblocks, the ... results during the discovery stage could lead to ... are frequently derived from discoveries made in university ... well known during clinical trials, which have a ...
Breaking Biology Technology:Pursuit's Peter Robinson Publishes "Grading Pharma's Use of New Commercial Sales Models" 2Gallus Enters Agreement with Progenics Pharmaceuticals, Inc. for Manufacture of Anti-PSMA Monoclonal Antibody 2Gallus Enters Agreement with Progenics Pharmaceuticals, Inc. for Manufacture of Anti-PSMA Monoclonal Antibody 3RENU 28 Skin Care Now Available in Australia and New Zealand 2Early bottlenecks in developing biopharmaceutical products delay commercialization 2Early bottlenecks in developing biopharmaceutical products delay commercialization 3
... DRRX ) announced today that a New ... submitted to the U.S. Food,and Drug Administration (FDA). ... formulation of oxycodone intended to treat moderate to ... designed to resist,common methods of prescription drug misuse ...
... to advance Merrimack,s robust pipeline of biologics ... targeting autoimmune disease and cancer, CAMBRIDGE, Mass., ... the discovery and development of,novel treatments for autoimmune disease and ... Series F private equity financing., Existing and new investors ...
... Bioheart, Inc.,(Nasdaq: BHRT ) today announced that ... common stock to the Nasdaq Capital Market. The Company,s,common ... to The,Nasdaq Capital Market at the opening of business ... a tier of the Nasdaq Stock Market for,companies with ...
Cached Biology Technology:New Drug Application Submitted for Remoxy(TM) (ORADUR(TM)-Based Oxycodone) 2New Drug Application Submitted for Remoxy(TM) (ORADUR(TM)-Based Oxycodone) 3New Drug Application Submitted for Remoxy(TM) (ORADUR(TM)-Based Oxycodone) 4New Drug Application Submitted for Remoxy(TM) (ORADUR(TM)-Based Oxycodone) 5Merrimack Pharmaceuticals Raises $60 Million in Private Financing 2Bioheart, Inc. to Transfer to Nasdaq Capital Market 2
Human Cystatin F MAb (Clone 292103)...
... Ac-DEVD-CHO is an inhibitor ... The concentration of inhibitor ... activity must be determined ... Ten micromolar inhibitor is ...
Human RELT/TNFRSF19L Affinity Purified Polyclonal Ab...
Mouse NOV/CCN3 Affinity Purified Polyclonal Ab...
Biology Products: